镰状细胞贫血中α基因、β单倍型及G6PD活性在基线与羟基脲治疗下的生物学影响
该回顾性研究纳入Créteil儿童队列中580例纯合HbS患者,评估α基因、β单倍型及G6PD活性在基线与羟基脲治疗下的生物学影响。基线时CAR单倍型与α基因数与Hb负相关、与LDH正相关;羟基脲治疗后BEN/BEN患者HbF和Hb水平高于CAR/CAR和SEN/SEN患者,作者认为BEN/BEN患者对羟基脲反应最佳。
要点
- 基线时CAR单倍型数和α基因数与Hb独立负相关、与LDH正相关。
- HbF与CAR单倍型数负相关,与BEN和SEN单倍型数正相关。
- 羟基脲治疗后BEN/BEN患者HbF和Hb水平高于CAR/CAR和SEN/SEN患者。
核心结论
- BEN/BEN患者对羟基脲反应最佳,作者认为这可能与这些患者中有利的BCL11A/rs1427407「T」等位基因频率较高有关。
研究设计与样本
- 回顾性研究,纳入Créteil儿童队列中具有α基因和β单倍型数据的纯合HbS患者580例(301例女性,279例男性)。
- 纯合β单倍型患者占74%(CAR/CAR 37.4%,BEN/BEN 24.3%,SEN/SEN 12.1%)。
- 168例队列镰状细胞贫血患儿接受羟基脲治疗。
主要发现
- 基线时CAR单倍型数和α基因数独立且与Hb负相关、与乳酸脱氢酶正相关。
- HbF与CAR单倍型数负相关,与BEN和SEN单倍型数正相关。
- 对HbF表达有利的BCL11A/rs1427407「T」等位基因与BEN单倍型数正相关、与CAR单倍型数负相关。
- 羟基脲治疗下,Δ值和HbF值与BEN单倍型数正相关。
- BEN/BEN患者HbF和Hb水平高于CAR/CAR和SEN/SEN患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sickle cell anemia (SCA), albeit monogenic, has heterogeneous phenotypic expression, mainly related to the level of hemoglobin F (HbF). No large cohort studies have ever compared biological parameters in patients with major β-globin haplotypes; ie, Senegal (SEN), Benin (BEN), and Bantu/Central African Republic (CAR). The aim of this study was to evaluate the biological impact of α genes, β haplotypes, and glucose-6-phosphate dehydrogenase (G6PD) activity at baseline and with hydroxyurea (HU). Homozygous HbS patients from the Créteil pediatric cohort with available α-gene and β-haplotype data were included (n = 580; 301 females and 279 males) in this retrospective study. Homozygous β-haplotype patients represented 74% of cases (37.4% CAR/CAR, 24.3% BEN/BEN, and 12.1% SEN/SEN). HU was given to 168 cohort SCA children. Hematological parameters were recorded when HbF was maximal, and changes (ΔHU-T0) were calculated. At baseline, CAR-haplotype and α-gene numbers were independently and negatively correlated with Hb and positively correlated with lactate dehydrogenase. HbF was negatively correlated with CAR-haplotype numbers and positively with BEN- and SEN-haplotype numbers. The BCL11A/rs1427407 "T" allele, which is favorable for HbF expression, was positively correlated with BEN- and negatively correlated with CAR-haplotype numbers. With HU treatment, Δ and HbF values were positively correlated with the BEN-haplotype number. BEN/BEN patients had higher HbF and Hb levels than CAR/CAR and SEN/SEN patients. In conclusion, we show that BEN/BEN patients have the best response on HU and suggest that this could be related to the higher prevalence of the favorable BCL11A/rs1427407/T/allele for HbF expression in these patients.
引用
- Bernaudin F, Arnaud C, Kamdem A, et al. Biological impact of α genes, β haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea. Blood Adv. 2018. PMID: 29555644. doi:10.1182/bloodadvances.2017014555
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。